ENZ Stock Price, Chart, Stats & News

Enzo Biochem, Inc.
Save
ENZ chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 44.12% |
Operating margin | -40.41% |
Pretax margin | -33.55% |
Net margin | -38.60% |
Effective tax rate | -8.85% |
ROA | -12.12% |
ROE | -16.78% |
D/E | 0.07x |
Interest coverage ratio | – |
ENZ valuation
P/E | – |
P/S | 0.82x |
P/B | 0.38x |
P/CF | -1.16x |
P/FCF | -1.09x |
P/OCF | -1.16x |
PEG | -0.88x |
EV multiple | -6.96x |
About
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics.
Similar securities
Based on sector and market capitalization
Report issue











